Volume 14, Number 3—March 2008
Research
Genetic Variability of West Nile Virus in US Blood Donors, 2002–2005
Andriyan Grinev*, Sylvester Daniel*, Susan L. Stramer†, Susan N. Rossmann‡, Sally Caglioti§, and Maria Rios*
Table 3
Deduced amino acid substitutions in 8 completely sequenced West Nile virus isolates compared with isolate WN-NY99*
| Isolate | NS4B |
NS5 |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2488 | 2549 | 2755 | 2788 | 2820 | 2826 | 2842 | 3056 | 3104 | 3132 | 3191 | 3238 | 3240 | ||
| WN-NY99 | Ser | Lys | Gly | Asn | Ser | Glu | Lys | Pro | Arg | Arg | Met | Gln | Pro | Total |
| FDA/HU-02 | 5 | |||||||||||||
| ARC10–02 | Gly | 3 | ||||||||||||
| BSL5–03 | Arg | 6 | ||||||||||||
| BSL5–04 | Ser | Arg | Lys | Gln | 8 | |||||||||
| GCTX1–05 | Arg | Ser | Leu | Arg | Cys | Ser | Thr | 16 | ||||||
| GCTX2–05 | Ser | 3 | ||||||||||||
| BSL2–05 | Gly | Arg | Gln | 10 | ||||||||||
| BSL13–05 | Gly | Arg | Gln | 8 | ||||||||||
*NS, nonstructural.
Page created: July 07, 2010
Page updated: July 07, 2010
Page reviewed: July 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.